Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. | CEO and President, Director | $213 K | -$26.3 K | -11% | May 15, 2024 |
SGTX | Sigilon Therapeutics, Inc. | Director | Aug 11, 2023 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|